Physician profile
Lara R Morris
NPI 1083721195
$5,371.57
in general payments reported to CMS, 2019-2025
34 companies · $974 in 2025
The $974 reported for 2025 was more than what 80% of Medical providers received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $155 · 2022: $964 · 2023: $1,717 · 2024: $1,561 · 2025: $974.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,135 · Education: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,135.22 |
| Education | $117.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $1,595.44 | 2022-2025 | Tezspire, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $503.36 | 2023-2025 | Trelegy Ellipta, Arexvy, Nucala |
| Harmony Biosciences LLC | $324.94 | 2022-2024 | Wakix |
| Grifols USA, LLC | $302.35 | 2021-2025 | Prolastin-C Liquid |
| Regeneron Healthcare Solutions, INC. | $284.31 | 2021-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $247.63 | 2021-2025 | |
| United Therapeutics Corporation | $215.85 | 2022-2025 | Tyvaso, Tyvaso, Orenitram |
| Philips North America LLC | $182.62 | 2022-2025 | (Ak6) Vest Therapy, Vest Therapy Und |
| Electromed, INC. | $161.65 | 2023-2025 | Smartvest |
| Gilead Sciences, INC. | $142.29 | 2021-2024 | |
| Baxter Healthcare | $138.98 | 2022-2024 | Hillrom - Life 2000 Ventilation System, Hillrom - Vest System Model 105 Home Care, Hillrom - Monarch Airway Clearance System |
| Mylan Specialty L.P. | $126.93 | 2022-2024 | Yupelri |
| Takeda Pharmaceuticals U.S.A., INC. | $125.81 | 2022-2024 | Glassia |
| Amgen INC. | $92.30 | 2021-2024 | Tezspire |
| Inspire Medical Systems, INC. | $80.85 | 2025 | Inspire |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $78.78 | 2021-2023 | Spiriva Respimat, Stiolto Respimat |
| Novartis Pharmaceuticals Corporation | $72.78 | 2022-2024 | |
| Actelion Pharmaceuticals US, INC. | $72.22 | 2024 | Opsumit |
| Insmed, INC. | $63.60 | 2023-2025 | Arikayce |
| Genzyme Corporation | $61.07 | 2023-2024 | |
| Pulmonx Corporation | $53.65 | 2023 | Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console, Chartis Catheter |
| Axsome Therapeutics, INC. | $50.98 | 2023-2024 | Sunosi |
| Inogen, INC. | $49.72 | 2022-2025 | |
| Mallinckrodt Hospital Products INC. | $47.71 | 2023-2024 | Acthar |
| Alexion Pharmaceuticals, INC. | $40.86 | 2023 | Ultomiris, Soliris |
| Abbvie INC. | $38.29 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $37.51 | 2021-2024 | Zerbaxa, Recarbrio |
| Bayer Healthcare Pharmaceuticals INC. | $36.52 | 2023-2024 | |
| Pharming Healthcare, INC. | $28.94 | 2023 | Ruconest |
| Viatris Specialty LLC | $27.16 | 2025 | Yupelri |
| Idorsia Pharmaceuticals US INC | $24.91 | 2022-2023 | Quviviq |
| Movair INC | $24.82 | 2025 | Luisa |
| Teva Pharmaceuticals USA, INC. | $19.03 | 2022 | |
| Coaptech, INC. | $17.71 | 2023 | Puma System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lara Morris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.